Medicare Enrolled
Dr. Jaishree Manohar, M.D.
Rheumatology · Sarasota, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Manohar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Manohar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Manohar
Dr. Jaishree Manohar is a rheumatology specialist in Sarasota, FL, with 16 years of NPI registration. Based on federal Medicare data, Dr. Manohar performed 157,103 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Manohar received a total of $25,558 from 41 pharmaceutical and/or device companies across 980 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Manohar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ Top 15% volume in FL
$25,558 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 116782 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗157,103
Medicare services
Top 15% in FL for rheumatology
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
59,400 | $4 | $20 |
| Tocilizumab injection (Actemra) | 35,230 | $5 | $10 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
29,750 | $10 | $50 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
12,488 | $34 | $100 |
| Denosumab injection (Prolia/Xgeva) | 7,620 | $18 | $27 |
| Romosozumab injection (Evenity) for osteoporosis | 6,510 | $8 | $12 |
| Rituximab injection, 10 mg Administration of a 10 mg dose of rituximab medication via injection. |
1,702 | $63 | $175 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
1,410 | $26 | $110 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,080 | $93 | $289 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
494 | $11 | $30 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
351 | $50 | $100 |
| Methotrexate sodium, 5 mg | 271 | $0 | $5 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
171 | $101 | $550 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
99 | $56 | $150 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
80 | $7 | $50 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
71 | $50 | $160 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
70 | $22 | $150 |
| Bone density scan (DEXA) of hip, pelvis, and spine This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures. |
62 | $50 | $125 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
61 | $62 | $200 |
| Injection, methylprednisolone acetate, 40 mg | 42 | $6 | $14 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
34 | $12 | $34 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
34 | $132 | $273 |
| Hyaluronan gel injection for joint An injection of hyaluronan gel into a joint to supplement joint fluid. This procedure is administered as a single dose. |
30 | $406 | $1,500 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
26 | $4 | $20 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
17 | $9 | $38 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
28.1% high complexity
70.9% medium
1.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,558
Total received (2018-2024)
Avg $3,651/year across 7 years
Top 17% in FL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
980
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,118
2023
$5,718
2022
$2,054
2021
$1,128
2020
$1,915
2019
$3,672
2018
$5,953
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$1,581
ABBVIE INC.
$770
Amgen Inc.
$515
Janssen Scientific Affairs, LLC
$416
UCB, Inc.
$308
Lilly USA, LLC
$276
AstraZeneca Pharmaceuticals LP
$231
E.R. Squibb & Sons, L.L.C.
$222
Janssen Biotech, Inc.
$193
GlaxoSmithKline, LLC.
$169
Boehringer Ingelheim Pharmaceuticals, Inc.
$120
Aurinia Pharma U.S., Inc.
$117
GENZYME CORPORATION
$74
PFIZER INC.
$55
Organon Llc
$25
Fresenius Kabi USA, LLC
$25
Sandoz Inc.
$20
Top 3 companies account for 56.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$3,226
PFIZER INC.
$2,316
Amgen Inc.
$2,277
AbbVie, Inc.
$2,153
Janssen Biotech, Inc.
$2,095
ABBVIE INC.
$2,013
Fresenius Kabi USA, LLC
$1,537
Lilly USA, LLC
$1,205
GlaxoSmithKline, LLC.
$1,129
UCB, Inc.
$1,109
Janssen Scientific Affairs, LLC
$1,018
AstraZeneca Pharmaceuticals LP
$700
E.R. Squibb & Sons, L.L.C.
$660
AbbVie Inc.
$518
Genentech USA, Inc.
$489
GENZYME CORPORATION
$456
Radius Health, Inc.
$370
Celgene Corporation
$370
Horizon Therapeutics plc
$361
Aurinia Pharma U.S., Inc.
$331
Boehringer Ingelheim Pharmaceuticals, Inc.
$241
Flexion Therapeutics, Inc.
$125
Theravance Biopharma, Inc.
$118
Actelion Pharmaceuticals US, Inc.
$95
Mallinckrodt LLC
$94
Mallinckrodt Hospital Products Inc.
$72
Mylan Institutional Inc.
$67
Medtronic USA, Inc.
$63
Johnson & Johnson Health Care Systems Inc.
$62
Sobi, Inc
$61
Sandoz Inc.
$42
Organon Llc
$25
TerSera Therapeutics LLC
$24
Mallinckrodt Enterprises LLC
$22
SANOFI-AVENTIS U.S. LLC
$20
Sebela Pharmaceuticals Inc.
$20
Hikma Pharmaceuticals USA
$20
SOBI, INC
$15
Kiniksa Pharmaceuticals, Ltd.
$14
Fidia Pharma USA Inc.
$13
FIDIA PHARMA USA INC.
$11
Top 3 companies account for 30.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · Cimzia · EVENITY · EVUSHELD · Enbrel · FORTEO · HUMIRA · HYMOVIS · HYRIMOZ · Humira · Hymovis · IDACIO · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · NUCALA · OFEV · ORENCIA · Otezla · PREVNAR 20 · Prolia · Quzyttir · RAYOS · REMICADE · RENFLEXIS · RIALTO · RIDAURA · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPEVIGO · STELARA · TALTZ · TAVNEOS · TREMFYA · Tymlos · VIBATIV · XELJANZ · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
25
County median income
$80,633
Nearest hospital to ZIP centroid (approximate)
SARASOTA MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Manohar is a mixed practice specialist, with above-average Medicare volume (top 15% in FL), with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Manohar experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Manohar performed 59,400 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Manohar receive payments from pharmaceutical companies?
Yes. Dr. Manohar received a total of $25,558 from 41 companies across 980 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Manohar's costs compare to other rheumatologists in Sarasota?
Dr. Manohar's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Manohar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Sarasota
Browse rheumatologists in Sarasota ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in FL
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in FL
Which FL rheumatologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology